Curriculum Vitae

PERSONAL DETAILS
BIOGRAPHY

 

Professor Hany Ariffin  is  Professor of Paediatrics and Head of the Division of Paediatric Haematology-Oncology and Bone Marrow Transplantation at the University of Malaya Medical Centre (UMMC). She also heads the Biobank Unit in the Faculty of Medicine, UM.  Her main research interest is childhood leukaemia and she has been the Malaysian lead for the Malaysia-Singapore (MASPORE) Leukaemia Study Group since 2003. Her other research areas include childhood cancer survivorship, stem cell transplantation and inherited cancers, particularly related to mutations in the tumour suppressor gene, TP53. In 2015, she won the Anugerah Akademik Negara award and in 2018 received the Distinguished Researcher Award from University Malaya. Professor Hany is a member of the paediatric oncology accreditation committee for the National Specialist Register,  co-chair of the Viva-Asia Bone Marrow Transplantation Consortium and a past president of the Malaysian Society of Paediatric Haematology-Oncology. Together with colleagues in the local fraternity, Professor Hany works to improve the outcome of children with cancer in Malaysia whilst ensuring equitable treatment for all irrespective of socio-economic standing. 

 

 

ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • CHAIRMAN, National, 01/01/2022 to present
  • Member; Transplantation Committee of UMMC, Faculty, 01/09/2021 to present
  • Memeber; Selection Panel for Anugerah Akademik Negara, National, 09/03/2021 to 01/02/2022
  • Member; Paediatric Haematology-Oncology Subspecialty Committee, National, 03/02/2021 to present
  • Committee Member; Taskforce Konsortium Biobank Kanser Negara, National, 02/04/2019 to present
  • AJK Tetap Proposal Defence Ijazah Tinggi, Faculty, 01/01/2021 to 31/12/2021
  • Committee Member; JK Penilaian dan Pemantauan Geran, Faculty, 01/01/2020 to 31/12/2021
  • Faculty Representative for Post-Graduate Assessment, Faculty, 20/02/2017 to 31/12/2021
  • Biobank, University Malaya, 01/01/2016 to 01/01/2021
  • Member; Jawatankuasa Tapisan Kenaikan Pangkat, Faculty, 08/10/2012 to 30/06/2021
  • Member; Medical Research Ethics Committee, University Malaya, 22/06/2017 to 31/12/2020
  • FRGS Monitoring and Evaluation Panel, University Malaya, 04/01/2016 to 30/12/2016
  • Head, UNIVERSITI MALAYA, 01/01/2015 to 31/12/2015
  • Committee Member, UMRG Grant Review Panel, Faculty,   to present
  • Faculty Representative , UM Higher Degree Examiners Committee, University Malaya,   to present
  • Committee Member, Research Grant Evaluation Panel, University Malaya,   to present
  • Committee Member, Selection Panel, UM Bright Sparks/SLAB/SLAI Program, University Malaya,   to present
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • PhD, ONKOLOGI(Paediatric Haematology & Oncology), UNIVERSITI MALAYA (UM)
  • MPaed(UM), PAEDIATRIC, UNIVERSITI MALAYA (UM)
  • MRCP (UK), PAEDIATRIC, ROYAL COLLEGE OF PHYSICIANS, UNITED KINGDOM
  • MBBS(UM), MEDICINE(PERUBATAN), UNIVERSITI MALAYA (UM)
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
  • Royal College of Paediatrics and Child Health, Fellow, Since 2011 (International)
  • Fellow of Royal College, Member, 2021 to 2021 (International)
SPECIALIZATION
(Area)
Area of Expertise
  • Paediatric Haematology-Oncology and BM Transplantation (Paediatric oncology)
  • Research Interest
  • Paediatric hemopoietic stem cell transplantation (stem cell transplantation, HSCT)
  • Role of p53 in childhood cancers (p53; TP53; Li-Fraumeni Syndrome)
  • Childhood cancer survivorship (Survivorship; premature aging; inflammaging)
  • TEACHING
    (Course Title),(Level of Study),(Institution),(Academic Session)
    Teaching
  • Master of paediatrics, Post Graduate, UNIVERSITY MALAYA (2007/2008 - )
  • Post-basic nursing degree (Oncology), Post Graduate, UNIVERSITY MALAYA (2007/2008 - 1 )
  • Clinical Oncology, Post Graduate, UNIVERSITY MALAYA (2011/2012 - 2 )
  • PUBLICATIONS
    (Title of publication in APA style)
    WoS
    2021
    • Chin, W. H. N., Li, Z. H., Jiang, N., Lim, E. H., Lim, J. Y. S., Lu, Y., . . . Yeoh, A. E. J. (2021). Practical Considerations for Using RNA Sequencing in Management of B-Lymphoblastic Leukemia Malaysia-Singapore Acute Lymphoblastic Leukemia 2020 Implementation Strategy. Journal of Molecular Diagnostics, 23(10), 1359-1372. doi: 10.1016/j.jmoldx.2021.07.013
    • Jiang, N., Wang, L. Z., Xiang, X. Q., Li, Z. H., Chiew, E. K. H., Koo, Y. M., . . . Yeoh, A. E. J. (2021). Intracellular vincristine levels in lymphoblasts affect treatment outcome in childhood B-lymphoblastic leukaemia: Ma-Spore ALL 2010 study. British Journal of Clinical Pharmacology, 87(4), 1990-1999. doi: 10.1111/bcp.14596
    • Chandrasekaran, S., Ramli, N., Ahmad, M. J., Effendi, I., Amir, N. N., Chow, R. C., . . . Kamalden, T. A. (2021). Premature Ocular Aging Features in Childhood Acute Lymphoblastic Leukemia Survivors. Journal of Adolescent and Young Adult Oncology, 10(4), 425-431. doi: 10.1089/jayao.2020.0064
    • Koschut, D., Ray, D., Li, Z. H., Giarin, E., Groet, J., Alic, I., . . . Nizetic, D. (2021). RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia. Oncogene, 40(4), 746-762. doi: 10.1038/s41388-020-01567-7
    • Bornstein, J., Roux, S., Petersen, L. K., Huang, L. M., Dobson, S. R., Pitisuttithum, P., . . . Luxembourg, A. (2021). Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine. Pediatrics, 147(1), 12. doi: 10.1542/peds.2019-4035
    • Peters, C., Dalle, J. H., Locatelli, F., Poetschger, U., Sedlacek, P., Buechner, J., . . . Party, E. P. D. W. (2021). Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study. Journal of Clinical Oncology, 39(4), 295-+. doi: 10.1200/jco.20.02529
    2020
    • Oh, L. X., Hainaut, P., Blanchet, S., Ariffin, H. (2020). Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles. Bmc Cancer, 20(1), 9. doi: 10.1186/s12885-020-6599-8
    • Ariffin, H., Ab Rahman, S., Jawin, V., Foo, J. C., Amram, N. F., Mahmood, N. M., . . . Lin, H. P. (2020). Haematopoietic stem cell transplantation for inborn errors of immunity: 25-year experience from University of Malaya Medical Centre, Malaysia. Journal of Paediatrics and Child Health, 56(3), 379-383. doi: 10.1111/jpc.14621
    • Chua, L. L., Rajasuriar, R., Lim, Y. A. L., Woo, Y. L., Loke, P., Ariffin, H. (2020). Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. Bmc Cancer, 20(1), 11. doi: 10.1186/s12885-020-6654-5
    • Chen, K. S., Bridges, C. R., Lynton, Z., Lim, J. W. C., Stringer, B. W., Rajagopal, R., . . . Bunt, J. (2020). Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma. Journal of Neuro-Oncology, 146(1), 41-53. doi: 10.1007/s11060-019-03352-3
    • Hrusak, O., Kalina, T., Wolf, J., Balduzzi, A., Provenzi, M., Rizzari, C., . . . Schrappe, M. (2020). Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. European Journal of Cancer, 132, 11-16. doi: 10.1016/j.ejca.2020.03.021
    • Li, Z. H., Jiang, N., Lim, E. H., Chin, W. H. N., Lu, Y., Chiew, K. H., . . . Yeoh, A. E. J. (2020). Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq. Leukemia, 34(9), 2418-2429. doi: 10.1038/s41375-020-0774-4
    • Ibrahim, H. M., Muda, Z., Othman, I. S., Unni, M. N. M., Teh, K. H., Thevarajah, A., . . . Alias, H. (2020). Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry. Bmj Open, 10(6), 9. doi: 10.1136/bmjopen-2020-037974
    • Azanan, M. S., Chandrasekaran, S., Rosli, E. S., Chua, L. L., Oh, L., Chin, T. F., . . . Ariffin, H. (2020). Retinal Vessel Analysis as a Novel Screening Tool to Identify Childhood Acute Lymphoblastic Leukemia Survivors at Risk of Cardiovascular Disease. Journal of Pediatric Hematology Oncology, 42(6), E394-E400. doi: 10.1097/mph.0000000000001766
    2019
    • Oh, L. X., Hafsi, H., Hainaut, P., Ariffin, H. (2019). p53, stem cell biology and childhood blastomas. Current Opinion in Oncology, 31(2), 84-91. doi:10.1097/cco.0000000000000504
    2018
    • Allen, E. J., Li, Z. H., Dong, D. F., Lu, Y., Jiang, N., Trka, J., . . . Wong, L. (2018). Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time-series gene expression profiling. British Journal of Haematology, 181(5), 653-663. doi:10.1111/bjh.15252
    • Li, J. F., Dai, Y. T., Lilljebjorn, H., Shen, S. H., Cui, B. W., Bai, L., . . . Huang, J. Y. (2018). Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proceedings of the National Academy of Sciences of the United States of America, 115(50), E11711-E11720. doi:10.1073/pnas.1814397115
    2014
    • Ariffin, H., Hainaut, P., Puzio-Kuter, A., Choong, S. S., Chan, A. S. L., Tolkunov, D., Rajagopal, G., Kang, W. F., Lim, L. L. W., Krishnan, S., Chen, K. S., Achatz, M. I., Karsa, M., Shamsani, J., Levine, A. J., Chan, C. S. (2014). Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome, Proceedings of the National Academy of Sciences of the United States of America. 111(43), 15497-15501
    • Lu, Y., Kham, S. K. Y., Ariffin, H., Oei, A. M. I., Lin, H. P., Tan, A. M., Quah, T. C., Yeoh, A. E. J. (2014). Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia, British Journal of Cancer. 110(6), 1673-16800007-0920.
    2013
    • Yan, J. L., Jiang, N., Huang, G. F., Tay, J. L. S., Lin, B. H., Bi, C. L., Koh, G. S., Li, Z. H., Tan, J., Chung, T. H., Lu, Y., Ariffin, H., Kham, S. K. Y., Yeoh, A. E. J., Chng, W. J. (2013). Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia, British Journal of Haematology. 163(1), 93-103
    2012
    • Madhloom, H. T., Kareem, S. A., Ariffin, H. (2012). An Image Processing Application for the Localization and Segmentation of Lymphoblast Cell Using Peripheral Blood Images, Journal of Medical Systems. 36(4), 2149-2158
    • Choong, S. S., Latiff, Z. A., Mohamed, M., Lim, L. L. W., Chen, K. S., Vengidasan, L., Razali, H., Rahman, E. J. A., Ariffin, H., Malaysian Soc, P. (2012). Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations, Clinical Genetics. 82(6), 564-568
    • Yeoh, A. E. J., Ariffin, H., Chai, E. L. L., Kwok, C. S. N., Chan, Y. H., Ponnudurai, K., Campana, D., Tan, P. L., Chan, M. Y., Kham, S. K. Y., Chong, L. A., Tan, A. M., Lin, H. P., Quah, T. C. (2012). Minimal Residual Disease-Guided Treatment Deintensification for Children With Acute Lymphoblastic Leukemia: Results From the Malaysia-Singapore Acute Lymphoblastic Leukemia 2003 Study, Journal of Clinical Oncology. 30(19), 2384-2392
    2011
    • Jiang, N., Koh, G. S., Lim, J. Y. S., Kham, S. K. Y., Ariffin, H., Chew, F. T., et al. (2011). BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia, Experimental Hematology. 393(321-329), Article
    • Leow, S., Kham, S. K. Y., Ariffin, H., Quah, T. C., Yeoh, A. E. J. (2011). FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemiaua study of 531 Southeast Asian children by the Ma-Spore study group, Hematological Oncology. 294(211-219), Article
    • Jiang, N., Kham, S. K. Y., Koh, G. S., Lim, J. Y. S., Ariffin, H., Chew, F. T., et al. (2011). Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL), Journal of Proteomics. 746(843-857), Article
    • Kwok, C. S. N., Quah, T. C., Ariffin, H., Tay, S. K. H., Yeoh, A. E. J. (2011). Mitochondrial D-loop Polymorphisms and Mitochondrial DNA Content in Childhood Acute Lymphoblastic Leukemia, Journal of Pediatric Hematology Oncology. 336(E239-E244), Article
    2010
    • Chong, S. Y., Chong, L. A., Ariffin, H. (2010). Accurate prediction of the needle depth required for successful lumbar puncture, American Journal of Emergency Medicine. 28(5), 603-606
    • Yeoh, A. E. J., Lu, Y., Chan, J. Y. S., Chan, Y. H., Ariffin, H., Kham, S. K. Y., et al. (2010). Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: Results from the Malaysia-Singapore ALL Study Group, Leukemia Research. 34(3), 276-283
    • Daud, S. S., Ibrahim, K., Choong, S. S., Vengidasan, L., Chong, L. A., Ariffin, H. (2010). Microfluidic chip-based assay for post-hematopoietic stem cell transplantation chimerism monitoring using polymorphic tandem repeat markers, Analytical Biochemistry. 397(2), 181-185
    2009
    • Patel, N., Krishnan, S., Offman, M. N., ..., Ariffin, H., et al. (2009). A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase, Journal of Clinical Investigation. 119(7), 1964-1973
    • Ariffin, H., Garcia, J. C., Daud, S. S., Ibrahim, K., Aizah, N., Ong, G. B., Chong, L. A., Mohamad, Z. (2009). GATA1 Mutations in Patients With Down Syndrome and Acute Megakaryoblastic Leukaemia Do Not Always Confer a Good Prognosis, Pediatric Blood Cancer. 53(1), 108-111
    2008
    • Ariffin, H., Martel-Planche, G., Daud, S. S., Ibrahim, K., Hainaut, P. (2008). Li-Fraumeni syndrome in a Malaysian kindred, Cancer Genetics and Cytogenetics. 186(0165-4608 ), 1
    • Ibrahim, K., Daud, S. S., Seah, Y. L., Yeoh, A. E., Ariffin, H. (2008). Rapid Detection of Prognostically Important Childhood Acute Lymphoblastic Leukemia Chimeric Transcripts Using Multiplex SYBR Green Real-Time Reverse Transcription PCR, Annals of Clinical and Laboratory Science. 38(0091-7370 ), 4
    • Kham, S. K. Y., Soh, C. K., Liu, T. C., Chan, Y. H., Ariffin, H., Tan, P. L., et al. (2008). Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore, European Journal of Clinical Pharmacology. 64(0031-6970 ), 4
    2007
    • Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., Wurm, M., Batish, S. D., Lach, F. P., Yetgin, S., Neitzel, H., Ariffin, H., Tischkowitz, M., Mathew, C. G., D Auerbach, A., Rahman, N. (2007). Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer, Nature Genetics. 39(2), 162-164
    • Ariffin, H., Chen, S. P., Kwok, C. S., Quah, T. C., Lin, H. P., Yeoh, A. E. J., Malaysia-Singapore Leukemia, S. (2007). Ethnic differences in the frequency of subtypes of childhood acute lymphoblastic leukemia: Results of the Malaysia-Singapore Leukemia Study Group, Journal of Pediatric Hematology Oncology. 29(1), 27-31
    2006
    • Ariffin, H., Ai, C. L., Lee, C. L., Abdullah, W. A. (2006). Cefepime monotherapy for treatment of febrile neutropenia in children, Journal of Paediatrics and Child Health. 42(12), 781-784
    • Kwok, C. S., Kham, S. K., Ariffin, H., Lin, H. P., Quah, T. C., Yeoh, A. E. (2006). Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL), Pediatric Blood Cancer. 47(3), 299-304
    Refereed Journals
    2021
    • Peters C, et al. Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study. J Clin Oncol. 2021 Feb 1;39(4):295-307. (WoS)
    • Bornstein J, et al. Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine. Pediatrics 2021 Jan;147(1):e20194035 (WoS)
    • Koschut D, Ray D, Li Z, Giarin E, Groet J, Ali I, Kham SK, Chng WJ, Ariffin H, Weinstock DM, Yeoh AE, Basso G, Ni eti D. RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia. Oncogene. 2021 Jan;40(4):746-762. (WoS)
    • Jiang N, Wang L, Xiang X, Li Z, Chiew EKH, Koo YM, Lee HS, Lin HP, Tan AM, Quah TC, Kham SKY, Goh BC, Ariffin H, Yeoh AE. Intracellular vincristine levels in lymphoblasts affect treatment outcome in childhood B-lymphoblastic leukaemia: Ma-Spore ALL 2010 study. Br J Clin Pharmacol. 2021 Apr;87(4):1990-1999. (WoS)
    • Chin, WC et al. Practical Considerations for Using RNA Sequencing in Management of B-Cell Acute Lymphoblastic Leukemia 2021; S1525-1578(21)00237-3
    • Yeoh AEJ, Oh BL, Ariffin H. Doing less, accomplishing more for childhood acute lymphoblastic leukaemia (ALL). Br J Haematol. 2021 ;194(4):661-662
    • Chandrasekaran S, Ramli N, Jamaluddin Ahmad M, Effendi I, Amir NN, Chow RC, Chee CKL, Azanan MS, Abd Ghafar SS, Ariffin H, Kamalden TA. Premature Ocular Aging Features in Childhood Acute Lymphoblastic Leukemia Survivors. J Adolesc Young Adult Oncol. 2020 Sep 30. doi: 10.1089/jayao.2020.0064. Epub ahead of print. PMID: 32996803. (WoS)
    2020
    • Ramli, N., Lim, C. H., Rajagopal, R., Tan, L. K., Seow, P., & Ariffin, H. (2020). Assessing changes in microstructural integrity of white matter tracts in children with leukaemia following exposure to chemotherapy. Pediatric Radiology, 1-7. (WoS)
    • Ariffin, H., Rahman, S.A., Jawin, V., Foo, J. C., Amram, N.F., Mahmood, N.M., Yap, T. Y., Rajagopal, R., Lum, S.H., Chan, L. L., Lin, H. P., Haematopoietic stem cell transplantation for inborn errors of immunity: 25 year experience from University of Malaya Medical Centre, Malaysia, Journal of Paediatrics and Child Health, DOI: 10.1111/jpc.14621 (WoS)
    • Chen KS, Bridges CR, Lynton Z, et al (2020). Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma. J Neurooncol ,146(1):41-53. (WoS)
    • Hrusak O, et al. (2020). Flash survey on severe acute respiratory syndrome coronovirus-2 infections in paediatric patients on anticancer treatment. European Journal of Cancer; 132: 11-16 (WoS)
    • Azanan MS, ...., Ariffin H. Retinal Vessel Analysis as a Novel Screening Tool to Identify Childhood Acute Lymphoblastic Leukemia Survivors at Risk of Cardiovascular Disease. J Pediatr Hematol Oncol. 2020 ; 46: 394-400 (WoS)
    • Li Z, et al. (2020) Identifying IGH disease clones for MRD monitoring in childhood B-cell acute lymphoblastic leukemia using RNA-Seq. Leukemia. Feb 25. doi: 10.1038/s41375-020-0774-4. [Epub ahead of print] (WoS)
    • Chua LL, ...Ariffin H. (2020). Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. BMC Cancer. 20(1):151. (WoS)
    • Oh L, Hainaut P, Blanchet S, Ariffin H. Expression of p53 N-terminal isoforms in Bcell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles. BMC Cancer 2020; 20(110):1-9 (WoS)
    2019
    • Ariffin H (2019). Challenges in Surviving Childhood Leukaemia. Lancet Haematology, 6(6): e288-9 (WoS)
    • Li CK. (2019). Care of adolescents and young adults with cancer in Asia: results of an ESMO/ SIOPE/SIOP Asia survey. ESMO Open 2019;4:e000467. (SCOPUS)
    • Oh,L, Hafsi H, Hainaut P, Ariffin H. (2019). p53, stem cell biology and childhood blastomas. Current Opinion Oncology, 31: 84-91 (WoS)
    2018
    • Yeoh AE, Li Z, Dong D, Lu Y, Jiang N, Trka J, Tan AM, Lin HP, Quah TC, Ariffin H, Wong L. Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time-series gene expression profiling. British Journal of Haematology 2018; 181: 653-663 (WoS)
    • Li, JF et al (2018). Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.Proc Natl Acad Sc , 115(50): 11711-11720 (WoS)
    • Chin TF, Ibrahim K, Thirunavakarasu T, et al. Nonclonal Chromosomal Aberrations in Childhood Leukemia Survivors. Fetal and Pediatric Pathology. 2018 Aug;37(4):243-253. DOI: 10.1080/15513815.2018.1492054. (WoS)
    • Yeoh AEJ, et al. Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study. J Clin Oncol 2018; 36(26): 2726-35 (WoS)
    2017
    • Qian M, et al. (2017) Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP (WoS)
    • Chua LL, Rajasuriar R, Azanan MS, Abdullah NK, Tang MS, Lee SC, Woo YL, Lim YA, Ariffin H, Loke P.. Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome. 2017;5(1):35. (WoS)
    • Hu S, Qian M, Zhang H, et al. (2017). Whole genome non-coding sequence analysis of T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations. Blood 129(24): 3264-3268 (WoS)
    • Ariffin H, Azanan MS, Abd Ghafar SS, et al. Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging. Cancer. 2017;123(21):4207 4214. doi:10.1002/cncr.30857 (WoS)
    • Tay CG, Lee VW, Ong LC, Goh KJ, Ariffin H, Fong CY. (2017). Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer; Aug; 64(8). doi. 10.1002/pbc.26471. (WoS)
    • Moriyama T, et al. (2017). Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry. Blood 130(10): 1209-13 (WoS)
    2016
    • Su Han Lum, Shi Jie How, , Hany Ariffin, Shekhar Krishnan. A four-point clinical criteria distinguishes immune thrombocytopenia from acute lymphoblastic leukaemia. Med J Malaysia 2016; 71(1): 28-9 (SCOPUS)
    • Azanan MS, Abdullah NK, Chua LL, Lum SH, Abdul Ghafar SS, Kamarulzaman A, Kamaruzzaman S, Lewin SR, Woo YL, Ariffin H, Rajasuriar R. Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus. Eur J Immunol. 2016 Jul;46(7):1715-26 (WoS)
    • Lum SH, Choong SS, Krishnan S, Mohamed Z, Ariffin H. 2016. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder. Singapore Med J 57(6):320-324 (WoS)
    • Rajagopal R, Abd-Ghafar S, Ganesan D, Bustam Mainudin A.Z., Wong K.T., Ramli N, Jawin V, Lum S.H., Yap T.Y., Bouffet E, Qaddoumi I, Krishnan S, Ariffin H and Abdullah W.A. 2016. Challenges of Treating Childhood Medulloblastoma in a Country With Limited Resources: 20 Years of Experience at a Single Tertiary Center in Malaysia. Journal of Global Oncology June 15, 2016, doi: 10.1200/JGO.2015.002659 (WoS)
    2015
    • Tay C.G., Ariffin, H., Yap, S., Rahmat, K., Sthaneshwar, P., Ong, L.C. (2014). Succinic semialdehyde dehydrogenase deficiency in a chinese boy: A novel ALDH5A1 mutation with severe phenotype. Journal of Child Neurology, 30(7),927-31. (WoS)
    • Ariffin H, Chan AS, Oh L, Abd-Ghafar S, Ong GB, Mohamed M, Razali H, Juraida E, Teo SH, Karsa M, Shamsani J, Hainaut P.2015. Frequent occurrence of gastric cancer in Asian kindreds with Li-Fraumeni syndrome.Clin Genet. 2015 Nov;88(5):450-5 (WoS)
    • Rajagopal R, Ariffin H, Krishnan S, Abdullah WA, Lin HP.2015. Pediatric Vaginal Yolk Sac Tumor: Reappraisal of Treatment Strategy in a Rare Tumor at a Unique Location.J Pediatr Hematol Oncol. 2015 Jul;37(5):391-5 (WoS)
    • Tay CG, Ariffin H, Yap S, Rahmat K, Sthaneshwar P, Ong LC. 2015. Succinic Semialdehyde Dehydrogenase Deficiency in a Chinese Boy: A Novel ALDH5A1 Mutation With Severe Phenotype.J Child Neurol ;30(7):927-31 (WoS)
    2014
    • Lu Y, Kham SK, Ariffin H, et al. Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia. Br J Cancer. 2014 ; Jan 16 (epub ahead of print) (WoS)
    • Ariffin H, Hainaut P, Puzio-Kuter A, et al. Whole- genome sequencing analysis of phenotypic heterogeneity and anticipation in Li Fraumeni cancer predisposition syndrome. Proc Nat Acad Sc 2014 ; 111(43): 15497-501 (WoS)
    • Lum SH, Chin TF, Lau KH, Yap TY, Rajagopal R, Ariffin H. Refractory acute monoblastic leukaemia with low hypodiploidy. Int J Hematol. 2014; 99(3): 215-6 (WoS)
    • Ariffin H, Geikowski A, Chin TF, Chau D, Arshad A, Abu Bakar K, Krishnan S. Griscelli syndrome. Med J Malaysia. 2014 ; 69(4):193-4 (SCOPUS)
    2013
    • Rajagopal R, Lum SH, Jalaludin MY, Krishnan S, Abdullah WA, Ariffin H. Hypercalcaemia: an unusual presenting feature of childhood acute lymphoblastic leukaemia. Br J Haematol. 2013 ; 163(2):147 (WoS)
    • Yan J, Jiang N, Huang G, Tay JL, Lin B, Bi C, Koh GS, Li Z, Tan J, Chung TH, Lu Y, Ariffin H, Kham SK, Yeoh AE, Chng WJ. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia. Br J Haematol 2013; 163(1): 93-103 (WoS)
    2012
    • Choong S, Latiff Z, Mohamed M, Lim L, Chen K, Vengidasan L, Razali H, Abdul Rahman E, Ariffin H; for Malaysian Society of Paediatric Haematology- Oncolody. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations.Clin Genet. 2012 ;82(6):564-8 (WoS)
    • Lim L, Chen KS, Krishnan S, Gole L, Ariffin H. Mature B- cell acute lymphoblastic leukaemia associated with a rare MLL-FOXO4 fusion gene. Br J Haematol. 2012 Mar 19. doi: 10.1111/j.1365-2141.2012.09091.x.[Epub ahead of print] (WoS)
    • Yeoh AE, Ariffin H, Chai EL, et al.Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the malaysia-singapore acute lymphoblastic leukemia 2003 study. J Clin Oncol 2012; 30(19): 2384-92 (WoS)
    • KB Loh, Ramli N, LK Tan, M Roziah, Rahmat K, Ariffin H. Quantification of diffusion tensor imaging in normal white matter maturation of early childhood using an automated processing pipeline. EUROPEAN RADIOLOGY Volume: 22 Issue: 7 Pages: 1413-1426 Mar 22.[Epub print ] (IF 4.34 Q1) (WoS)
    • Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Res. 2012 Apr 16;14(2):R61. (WoS/SCOPUS)
    2011
    • Jiang N, Koh GS, Suang Lim JY, Yin Kham SK, Ariffin H, Chew FT, Yeoh AE. BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. Exp Hematol. 2011 Mar;39 (3):321-329 (WoS)
    • Leow S, Kham SK, Ariffin H, Quah TC, Yeoh AE. FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemia-a study of 531 Southeast Asian children by the Ma-Spore study group.Hematol Oncol. 2011;29(6):211-9 (WoS)
    • Jiang N, Kham SK, Koh GS, Suang Lim JY, Ariffin H, Chew FT, Yeoh AE.Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL). J Proteomics. 2011; 74(6):843-57 (WoS)
    • Choong SS, Rosmanizam S, Ibrahim K, Gan GG, Ariffin H. Development of an algorithm of satellite markers for monitoring chimerism status in post-allogeneic haematopoietic stem cell transplantation patients. Int J Lab Hematol. 2011;33(2):182-6 (WoS)
    • Madhloom HT, Kareem SA, Ariffin H. An Image Processing Application for the Localization and Segmentation of Lymphoblast Cell Using Peripheral Blood Images. J Med Syst. 2011 Mar 12. [Epub ahead of print] (WoS)
    2010
    • Daud SS, Ibrahim K, Choong SS, Vengidasan L, Chong LA, Daud SS, Ibrahim K, Choong SS, Vengidasan L, Chong LA, Ariffin H, . Microfluidic chip-based assayfor post- hematopoietic stem cell transplantation chimerism monitoring using polymorphic tandem repeat markers. Anal Biochem 2010; 397(2):181-5 (WoS)
    • Yeoh AE, Lu Y, Chan JY, Chan YH, Ariffin H, Kham SK, Quah TC. Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: Results from the Malaysia-Singapore ALL Study Group. Leuk Res. 2010;34(3):276-283 (WoS)
    • Chong SY, Chong LA, Ariffin H. Accurate prediction of the needle depth required for successful lumbar puncture. Am J Emerg Med 2010 ; 28: 603-6 (WoS)
    • IC Sam, Abdul-Murad A, Karunakaran R, Rampal S, Chan YF, Nathan AM, Ariffin H. Clinical features of Malaysian children hospitalised with community-acquired seasonal influenza. IJID 14S(2010)e36-e40 (WoS)
    2009
    • Ariffin H, Garcia JC, Daud SS, Ibrahim K, Aizah N, Ong GB, Chong LA, Mohamad Z, 2009. GATA1 mutations in patients with Down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.Pediatr Blood Cancer. 2009 Jul;53(1):108-11. (WoS)
    • Patel N, Krishnan S, Offman MN, Krol M, Moss CX, Leighton C, van Delft FW, Holland M, Liu J, Alexander S, Dempsey C, Ariffin H, Essink M, Eden OB, Watts C, Saha V. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L- asparaginase. J Clin Invest 2009 ; 119 (7) : 1964-73 (WoS)
    2008
    • Kham SK, Soh CK, Liu TC, Chan YH, Ariffin H, et al. Thiopurine S-methyltransferase activity in three major Asian populations : a population-based study in Singapore. Eur J Clin Pharmacol 2008 ; 64(4) : 373 - 9 (WoS)
    • Ariffin H, Martel-Planche G, Daud SS, Ibrahim K, Hainaut P. Li-Fraumeni Syndrome in a Malaysian kindred 2008 ; 186(1): 49-53 (WoS)
    • Mah ESL, Muridan R, Cheng PS, Ariffin H, Ramanujam TM. Supratentorial primitive neuroectodermal tumour with thoracic metastases. J Pediatr Neurol 2008 ; 6(2): (Non-WoS/Non-SCOPUS)
    • Ibrahim K, Daud SS, Seah YL, Yeoh AE, Ariffin H. Rapid detection of prognostically important childhood ALL chimeric transcripts using multiplex SYBR-Green reverse transcription real-time PCR. Ann Clin Lab Sci 2008; 38(4): 338 -43 (WoS)
    2007
    • Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genetics 2007; 39(2): 162 -4 (WoS)
    • Lu Y, Kow-Yin Kham S, Foo TC, Hany A, Quah TC, Yeoh A. Genotyping of eight polymorphic genes encoding drug-metabolizing enzymes and transporters using a customized oligonucleotide array. Anal Biochem. 2007; 360(1):105-13. (WoS)
    • Menon BS, Juraida E, Alagaratnam J, Mohammad M, Ibrahim H, George TM, Ariffin H, Ho C, Khuzaiah R, Lin HP; for the Malaysian Children's Cancer Study Group. Chemoreduction for Intraocular Retinoblastoma in Malaysia. J Pediatr Hematol Oncol 2007 ; 29(1) : 2-4 (WoS)
    • Sithasanan N, Chong LA, Ariffin H. Spontaneous splenic rupture secondary to phaeohyphomycosis and splenic abscess. Med J Malaysia 2007; 62(3) : 247 8 (WoS)
    • Ariffin H, Chen SP, Kwok CS, Quah TC, Lin HP, Yeoh AE; for the Malaysia-Singapore Leukemia Study Group. Ethnic Differences in the Frequency of Subtypes of Childhood Acute Lymphoblastic Leukemia: Results of the Malaysia-Singapore Leukemia Study Group. J Pediatr Hematol Oncol 2007 ; 29(1) : 27 -31 (WoS)
    • Daud SS, Ibrahim K, Ariffin H. Quantitative evaluation of chimerism status following stem cell transplantation using a microchip electrophoresis system. JUMMEC 2007; 10(1): 11-16 (Non-WoS/Non-SCOPUS)
    • Ariffin H, Daud SS, Mohamed Z, et al. Evaluation of two short tandem repeat multiplex systems for post haematopoietic stem cell transplantation chimerism analysis. Singapore Med J 2007: 48(4) : 333 7 (SCOPUS)
    2006
    • Kwok CS, Kham SK, Ariffin H, et al. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2006 ; 47(3) : 299 304 (WoS)
    • Ariffin H, Chong LA, Chan LL, Abdullah WA. Cefepime monotherapy for treatment of febrile neutropenia in children. J Paed Child Health 2006 ; 42(12) : 781 4 (WoS)
    2005
    • Ariffin H, Muthukkumaran T, Stanslas J , et al . Secondary acute lymphoblastic leukaemia following Wilms tumour: clinical and in vitro chemosensitivity studies. Leuk Lymphoma 2005: 46(8): 1233 7
    • Ariffin H , Lim HL . Surveillance blood counts for early detection of relapse in acute lymphoblastic leukemia. Pediatr Blood Cancer 2005 ; 45(2) : 229 (WoS)
    • Ariffin H , Lum SH , Cheok SA, et al. Haemophagocytic lymphohistiocytosis in Malaysian children . J Paediatr Child Health 2005 ; 41(3) : 136-9 (WoS)
    2004
    • Ariffin H, et al. , "Antibiotic resistance patterns in nosocomial gram-negative bacterial infections in units with heavy antibiotic usage ", 2004, J Trop Pediatr, Vol. 50, no. 1, pg. 26-31
    2003
    • Ariffin H, et al, "Prenatal exclusion of severe Factor VII deficiency ", 2003, J Pediatr Hematol Oncol, Vol. 25, no. 5, pg. 418-20
    • Ariffin H, "Severe vincristine neurotoxicity with concomitant use of itraconazole ", 2003, J Paediatr Child Health, Vol. 39, no. 8, pg. 638
    • Ariffin H, et al, "Validation of a multiplex RT-PCR assay for screening significant oncogene fusion transcripts in children with acute lymphoblastic leukaemia ", 2003, Singapore Med J, Vol. 44, no. 10, pg. 517-20 (WoS)
    2002
    • Ariffin H , Parasakthi N , Lin HP. Surveillance study of bacteremic episodes in febrile neutropenic children . Int J Clin Practice 2002 ; 56(4) : 237 - 40 (WoS)
    • Ariffin H . Late effects of childhood cancer therapy . J Paed Obst Gynaecology 2002 ; 28(5) : 5 -9 (Non-WoS/Non-SCOPUS)
    • Ariffin H , Parasakthi N , Lin HP, "Surveillance study of bacteremic episodes in febrile neutropenic children", Int J Clin Pract 2002, Vol. 56, no. 4, pg. 237-40 (WoS)
    2001
    • 14)Ariffin H , Arasu A , Mahfuzah M , et al. Single-daily ceftriaxone plus amikacin vs thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer . J Paed Child Health 2001; 37(1) :38 - 43 (WoS)
    2000
    • Parasakthi N , Vadivelu J , Ariffin H , Iyer L , Selvi P , Arasu A . Epidemiology and molecular characterisation of nosocomially-transmitted multi-resistant Klebsiella pneumoniae . Int J Infect Dis 2000 ; 4 : 123 -8 (WoS)
    • Omar KZ, Ariffin H , Lin HP , Ariffin WA , Chan LL . Complications of L-asparaginase therapy in childhood leukemia . Int J Ped Hematol Oncol 2000 ; 7 (3) : 225 - 33 (WoS)
    • Omar KZ , Ariffin H , Ariffin WA , Chan LL , Lin HP . Streptokinase infusion for asparaginase-induced arterial thrombosis . Med Pediatr Oncol 2000 ; 34(5) : 377-8 (WoS)
    • Ariffin H , Ariffin WA , Chan LL, Lin HP. Wilms' tumour and Fanconi anemia ; an unusual association . J Paed Child Health 2000 ; 36(2) : 196-7 (WoS)
    1999
    • Ariffin H , Ariffin WA , Omar A , deBruyne JA , Chan LL , Lin HP . Successful treatment of Candida albicans endocarditis in a child with leukemia . Singapore Med J 1999 ; 40 (8) : 533 - 6 (WoS)
    • Chan LL , Lin HP , Ariffin WA , Ariffin H , Saw MH. Treating high-risk childhood solid tumours with autologous peripheral stem-cell transplantation -- early experience in University Hospital , Kuala Lumpur. Med J Malaysia 1999: 54 (2): 175-9 (WoS)
    • Ariffin H , Parasakthi N, Mahfuzah M , Arasu A , Ariffin WA , Chan LL , Lin HP . Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia . Int J Infect Dis 1999 ; 4 : 21 - 25 (WoS)
    • Ariffin H , Ariffin WA , Mahfuzah M , Arasu A , Lin HP . Treatment of systemic Fusarium infection in children with leukemia . Med Pediatr Oncol 1999 ; 33 (6) : 598 - 9 (WoS)
    1998
    • Mahfuzah M , Ariffin H , Arasu A , Soo-Hoo TS , Ariffin WA , Lin HP . Systemic Fusarium infection in children with cancer ; a report of two cases . Malaysian J Child Health 1998 ; 10(2) : 55-7 (Non-WoS/Non-SCOPUS)
    1997
    • Ariffin H , Lin HP. Neonatal intracranial haemorrhage secondary to congenital factor VII deficiency : Two case reports . Am J Hematology 1997 ; 54 (3) : 263 (WoS)
    • Ariffin H , Ariffin WA , Wong KT ,Raman TM , Lin HP. Intra-abdominal desmoplastic small round cell tumour in an 11-year old boy . Singapore Med J 1997; 38:169 - 71 (WoS)
    • Ariffin H , Ariffin WA , Lin HP , Parasakthi N . Septicemia in paediatric cancer patients : A 5-year surveillance study . J Trop Paediatr 1997 ; 45 (3) : 279 - 81 (WoS)
    • Ariffin H , Ariffin WA , de Bruyne JA , Chan LL , Lam SK , Lin HP . Belief in traditional healers amongst Malaysian parents of children with cancer. J Trop Paediatr 1997 ; 43 : 375 - 6 . (WoS)
    • Ariffin H , Ariffin WA , Chan LL , Lam SK , Lin HP . Second malignant neoplasms : An increasingly- recognised complication in childhood cancer survivors . Med J Malaysia 1997 ; 52 (2 ) : 174 77 (SCOPUS)
    1996
    • Hany A, Thong MK, Lin HP. X-linked lymphoproliferative disease in a Malaysian family. Singapore Med. Journal 1996; 37: 325-7. (SCOPUS)
    • A Hany , Thong MK , Lin HP. Two brothers in a Malaysian family with the X - linked ymphoproliferative disease. Singapore Med J 1996 : 37 : 325 - 7 (SCOPUS)
    Book
    1996
    • Hamzah Sendut I, Ismail Z, Ariffin H. 1996. Pediatric Picture Tests for Medical Students. Kuala Lumpur, Pelanduk Publications (Non-WoS/Non-SCOPUS)
    Book Chapter
    2021
    • Achatz M.I., Prolla P.A., Ariffin H., Hainaut P. (2021) Inherited Pediatric Cancer in Low- and Intermediate-Resource Countries. In: Malkin D. (eds) The Hereditary Basis of Childhood Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-74448-9_12
    2020
    • Ariffin H. (2020). Leukemia and Lymphoma. Textbook of Paediatrics and Child Health. Lee WS, Tay CG, Lum SH (eds). University of Malaya Press
    2005
    • Hany Ariffin, 2005. " Usage of Blood Products" in LeeWS , ThongMK, Wong CP (eds)Handbook of Hospital Pediatrics. pp 154-6. (Non-WoS/Non-SCOPUS)
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    BKP
  • 'PERIPHERAL NEUROPATHY IN SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, Consultant, 2012 - 2014 (National)
  • NUS
  • MASPORE ALL 2010 , Principal Investigator(PI), 2010 - 2017 (National)
  • MASPORE AML, Principal Investigator(PI), 2007 (National)
  • MOSTI
  • Development of a robust chimerism analysis system following stem cell transplantation , Principal Investigator(PI), 2008 - 2010 (National)
  • IARC,WHO
  • Li-Fraumeni Syndrome in Malaysia , Principal Investigator(PI), 2008 - 2010 (National)
  • MOHE
  • Asparaginyl endopeptidase in childhood cancer , Principal Investigator(PI), 2007 - 2008 (National)
  • WT-1 gene in acute myeloid leukemia, Coordinator, 2007 - 2008 (University)
  • Malaysia-Singapore AML2006 Study , Principal Investigator(PI), 2006 - 2008 (International)
  • Quantitative chimerism analysis using microchip electrophoresis system, Principal Investigator(PI), 2006 - 2008 (University)
  • MAKNA
  • Expression of TERF-2 and hTERT in childhood acute lymphoblastic leukemia, Coordinator, 2007 - 2008 (University)
  • Minimal Residual Disease assessment via flow cytometry, Principal Investigator(PI), 2000 - 2002 (University)
  • Oncogene Fusion Transcripts in Acute Lymphoblastic Leukemia, Principal Investigator(PI), 2005 - 2008 (University)
  • Short Term Research Fund (Vote F)(PJP)
  • Chimerism analysis using short tandem repeats, Principal Investigator(PI), 2005 - 2006 (University)
  • Singapore Cancer Syndicate, AStar
  • Malaysia-Singapore Acute Lymphoblastic Leukemia Study , Consultant, 2003 - 2008 (International)
  • Fundamental Research Grant Scheme (FRGS)
  • Mechanistic Insights Into Wild-type P53 Activity In Childhood Cancers, Using In Silico Prediction And In Vitro Modelling, Principal Investigator(PI), 07/09/2021 to 06/09/2024, Kementerian Pengajian Tinggi (KPT) (Government)
  • International Funding
  • Match 2021: P53 Isoforms In Childhood Cancers, Co-Researcher, 01/08/2021 to 31/07/2023, Kementerian Pendidikan Malaysia (KPM) (Government)
  • MOSTI-International Collaboration Fund (ICF)
  • Maspore-all 2020: Improving Risk Assignment And Treatment Outcome In Childhood Acute Lymphoblastic Leukaemia Through Precision Medicine And Immunotherapy, Principal Investigator(PI), 01/03/2020 to 31/08/2022, Ministry of Energy, Science, Technology, Environment And Climate Changes (Government)
  • Others MOHE - Top 100 (IIRG)-HWB
  • Improving Survical Quality Of Childhood Cancer Via Safer And More Effective Hla-haploidentical Haemopioetic Stem Cell Transplantatio, Principal Investigator(PI), 13/05/2019 to 12/11/2021, Kementerian Pendidikan Tinggi (KPT) (Government)
  • Improving Survival Quality Of Childhood Cancer Via Lifestyle Modifications, Co-Researcher, 13/05/2019 to 12/11/2021, Kementerian Pendidikan Tinggi (KPT) (Government)
  • Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness)
  • P53 Isoforms As New Therapeutic Target In Childhood Cancers, Co-Researcher, 29/11/2017 to 29/11/2019, Research University (Government)
  • Elucidating The Aetiology Of Second Cancers In Childhood Cancer Survivors, Principal Investigator(PI), 29/11/2017 to 29/11/2019, Research University (Government)
  • SUPERVISION
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Completed
    • Role of p53 in Childhood Cancers., OH LIXIAN, University of Malaya (PhD)
    • Instituting Robust In-House Karyotyping as Part of Standard Diagnostic and Management for Children with Acute Lymphoblastic Leukemia, CHEN KOK SIONG, University of Malaya (MASTER)
    • -, LUM SU HAN, University of Malaya (MASTER)
    • -, ANIS SIHAM BINTI ZAINAL ABIDIN, University of Malaya (MASTER)
    • -, LIM HUAY LING, University of Malaya (MASTER)
    • Late Effects in Childhood Leukemia Survivors: Relationship of Immune Dysregulation and Cytomegalovirus Infection with Cardiometabolic Risk Factors and Endothelial Dysfunction, MOHAMAD SHAFIQ AZANAN, University of Malaya (PhD)
    • Li-Fraumeni syndrome in Malaysian Families, CHOONG SOO SIN, University of Malaya (MASTER)
    • INSERTION DELETION POLYMORPHISMS AS MARKERS FOR QUANTITATIVE CHIMERISM ANALYSIS IN POST ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION USING A SYBR GREEN REAL-TIME PCR PLATFORM, KAMARIAH BINTI IBRAHIM, University of Malaya (MASTER)
    • Clinical features and biological factors in neuroblastoma, Shanti Ramachandran, University of Malaya (UM) (Post Graduate Student)
    • GATA1 mutations in abnormal myelopoeisis in children with Down Syndrome, Lum Su Han, University of Malaya (UM) (Post Graduate Student)
    • IDENTIFICATION OF RB1 GERM LINE MUTATIONS IN PATIENTS WITH RETINOBLASTOMA, KAVIMALAR A/P RENGANATHAN, University of Malaya (MASTER)
    • -, LIM HUAY LING, University of Malaya (UM) (Post Graduate Student)
    • GUT MICROBIOATA DYSBIOSIS IN CHILDREN AND ADULT SURVIVORS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKIMIA, CHUA LING LING, University of Malaya (PhD)
    • -, HON SAI KIT, University of Malaya (MASTER)
    • -, CHONG SZE YEE, University of Malaya (MASTER)
    • QUANTITATIVE RT-PCR ANALYSIS OF WILM'S TUMOUR 1 (WT1) GENE FOR MINIMAL RESIDUAL DISEASE MONITORING IN CHILDHOOD ACUTE MYLEOID LEUKEMIA, SITI SARAH BINTI DAUD, University of Malaya (MASTER)
    • -, SHANTI A/P RAMACHANDRAN, University of Malaya (MASTER)
    • -, SHANTI A/P RAMACHANDRAN, University of Malaya (MASTER)
    • CYTOGENETIC RISK STRATIFICATION OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA USING KARYOTYPING AND FLUORESCENT IN SITU HYBRIDISATION (FISH), CHIN TONG FOH, University of Malaya (MASTER)
    • Role of Full Blood Count in detecting relapse in children with acute lymphoblastic leukemia, Lim Huay Ling, University of Malaya (UM) (Post Graduate Student)
    Ongoing
    • -, EVERLYN COXIN SIEW, University of Malaya (MASTER)
    • , GAN CHAI PHEI, University of Malaya (PhD)
    • Molecular quantitative chimerism analysis on post-transplantation haematopoeitic stem cells using insertion-deletion polymorphic markers, KAMARIAH IBRAHIM, University of Malaya (UM) (Post Graduate Student)
    • Late Effects in Childhood Leukemia Survivors: Relationship of Immune Dysregulation and Cytomegalovirus Infection with Cardiometabolic Risk Factors and Endothelial Dysfunction, MOHAMAD SHAFIQ AZANAN, University of Malaya (UM) (Post Graduate Student)
    • Role of p53 in Childhood Cancers., OH LIXIAN, University of Malaya (UM) (Post Graduate Student)
    • -, NIN BUN SAN, University of Malaya (UM) (Post Graduate Student)
    • Association Between Gut Microbiome Dysbiosis With Systemic Immune Activation, Inflammation and Pre-Mature Age-Related Comorbidities, CHUA LING LING, University of Malaya (UM) (Post Graduate Student)
    • CYTOGENETIC RISK STRATIFICATION OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA USING KARYOTYPING AND FLUORESCENT IN-SIFU HYBRIDIZATION (FISH), CHIN TONG FOH, University of Malaya (UM) (Post Graduate Student)
    • RB1 gene mutation in Malaysian Children with Retinoblastoma, Kavimalar Renganathan, University of Malaya (UM) (Post Graduate Student)
    • Image Processing Applications for the Localization and Segmentation of Blast Cells Using Peripheral Blood Images, Hayan Tariq Madhloom, University of Malaya (UM) (Post Graduate Student)
    • Li-Fraumeni Syndrome in Malaysian Families, Choong Soo Sin, University of Malaya (UM) (Post Graduate Student)
    • Karyotyping of childhood and adult leukaemia, Chen Kok Siong, University of Malaya (UM) (Post Graduate Student)
    • Depth of needle during lumbar puncture in children, CHONG SZE YEE, University of Malaya (UM) (Post Graduate Student)
    • WT-1 as a marker of minimal residual disease in childhood acute myeloid leukemia, SITI SARAH DAUD, University of Malaya (UM) (Post Graduate Student)
    • -, CHIN KAR PUI, University of Malaya (MASTER)
    • Childhood rhabdomyosarcoma, ANIS SIHAM, University of Malaya (UM) (Post Graduate Student)
    UG Student/Clinical Fellowship
    (Title of Thesis),(Academic Session)
    Completed
    • In vitro assessment of the efficacy of standard chemotherapeutic drugs used in childhood leukemia, 2000/2001
    • Efficacy of chemotherapeutic drugs against primary and relapsed childhood leukemic cells, 2002/2003
    • Evaluation of engraftment status following HSCT using multiplex PCR amplification of selected short tandem repeats, 2005/2006
    • Screening for oncogene fusion transcripts in acute lymphoblastic leukemia using multiplex RT-PCR assay, 2005/2006
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • Blood donation , 19/08/2021 to 19/08/2021 (National)
    • Coordinating public donation of personal protective equipment to hospital during the SARS-Co-V2 pandemic , 01/04/2020 to 01/10/2021 (University)
    • Member; Subspeciality Credentialling Subcommittee for paediatric haematology-oncology, 01/01/2014 to 31/12/2016
    • President, Malaysian Society of Paediatric Oncology, 07/07/2011 to 31/07/2012
    COURSE ATTENDED
    (Course Title),(Venue),(Duration),(Level)
    External Course
  • VIVA-Asia Bone Marrow Transplantation Autumn School, Hosted by Nus Singapore, 20/11/2021 to 21/11/2021 (International)
  • ACADEMIC/PROFESSIONAL SERVICES
    Academic/Professional Services
    (Contribution),(Duration),(Level),(Role)
  • Translational Research Grant Scheme 2022, 20/04/2022 to 29/04/2022, National, (External Evaluator)
  • World Cancer Research Fund International Grant Application 2022, 06/04/2022 to 09/04/2022, International, (External Evaluator)
  • Article "Down with Blood Cancer" in the Star newspaper, 20/03/2022 to 20/03/2022, National, (Discourse)
  • Expert Panel for R&D Funding Applications, MOSTI, 01/01/2022 to 31/12/2022, National, (External Evaluator)
  • APJCO-2021-0501.R1 entitled "Life-Threatening Infections During Treatment for Acute Lymphoblastic Leukemia, 04/12/2021 to 04/12/2021, International, (Reviewer)
  • Draft Manuscript: Penyakit Imunodeficiensi Primer Siri 1, 30/11/2021 to 31/12/2021, National, (Reviewer)
  • Star Health article : Covid19 and Children with Cancer, 26/09/2021 to 26/09/2021, National, (Interview)
  • Rancangan Helo Doktor TV3 Siri4, 12/09/2021 to 12/09/2021, National, (Panelist/Moderator)
  • Promotion Exercise to Full Professor (USM), 16/08/2021 to 18/08/2021, National, (External Assessor)
  • Evaluation of new pharmaceutical agents, 16/02/2021 to 31/12/2021, National, (External Assessor)
  • Evaluation Activity
    (Activity),(Duration),(Category)
  • Medical Pediatric Oncology ,   (Article)
  • Journal of Pediatric Hematology/Oncology ,   (Article)
  • Pediatric Blood and Cancer ,   (Article)
  • Pediatric Hematology Oncology,   (Article)
  • AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • Distinguished Researcher , University of Malaya, 2018 (RESEARCH)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2017 (CERTIFICATE)
    • KHIDMAT SETIA 20 AWARD, , 2015 (CERTIFICATE)
    • UM EXCELLENCE AWARD, NAIB CANSELOR, 2015 (CERTIFICATE)
    • Anugerah Akademik Negara, Kementerian Pengajian Tinggi, 2015 (SPECIAL)
    • UM EXCELLENCE AWARD, , 2012 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2011 (CERTIFICATE)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2008 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2007 (CERTIFICATE)
    • UICC (International Union Against Cancer) Fellowship, CancerResearch-UK Clinical Centre, London, United Kingdom, 2006 (SPECIAL)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2006 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2005 (CERTIFICATE)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2005 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2004 (CERTIFICATE)
    • UICC (International Union Against Cancer) Fellowship, Sir James Spence Institute of Child Health , Royal Victoria Infirmary , Newcastle-Upon-Tyne, 2002 (SPECIAL)
    • Cancer Research Award, National Cancer Council of Malaysia (MAKNA), 2001 (SPECIAL)
    • Young Investigator Travel Scholarship, International Society of Paediatric Oncology (SIOP), 2000 (SPECIAL)
    • Bill Marshall Memorial Fellowship, Great Ormond Street Hospital and Institute of Child Health, London, 2000 (SPECIAL)
    • Young Investigator Award, International Society for the Immunocompromised Host, 1998 (SPECIAL)
    • Postgraduate Merit Award, Malaysian Paediatric Association, 1998 (SPECIAL)
    • Young Investigator Travel Award, International Society of Chemotherapy, 1997 (SPECIAL)
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • 15th StJude-VIVA Forum on Paediatric Oncology, VIVA Foundation, 05/03/2021 to 13/03/2021, Coordinator (International)
    • Chimerism analysis following bone marrow transplantation, Sime Darby Technology Corp, 01/11/2007 to 01/11/2008 (National)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    CONFERENCE
  • Surviving childhood leukemia, MASPHO 19th Annual Scientific Meeting 2014, 20/09/2014 to 21/09/2014, Malaysian Society of Paediatric Haematology and Oncology (MASPHO) (National)
  • Lab tests in leukemia diagnosis, Annual General Meeting Malaysian Institute of Medical Laboratory Sciences (MIMLS) , 23/09/2013 to 24/09/2013, Malaysian Institute of Medical Laboratory Sciences (MIMLS)  (National)
  • Tumour Lysis Syndrome, Malaysian Society of Paediatric Haematology and Oncology (MASPHO), 21/09/2013 to 22/09/2013, Malaysian Society of Paediatric Haematology and Oncology (MASPHO) (National)
  • PLEANARY SPEAKER
  • Malaysia and Singapore Experience in Paediatric Acute Lymphoblastic Leukemia Treatment, ALL Academy of South-East Asia and Hong Kong, 27/01/2022 to 27/01/2022, Amgen (International)
  • HLA-haploidentical BMT for children, 17th Malaysian Society of Haematology Annual Scientific Meeting (MSH 2020), 12/09/2020 to 12/09/2020, Malaysian Society of Haematology  (National)
  • Inherited Bone Marrow Failure Syndromes, 17th Malaysian Society of Haematology Annual Scientific Meeting (MSH 2020), 10/09/2020 to 10/09/2020, Malaysian Society Of Haematology (National)
  • Therapeutic Triumphs in Childhood ALL, 3rd International Conference on Medical and Health Sciences 24th National Conference on Medical and Health Sciences (3rd ICMHS & 24th NCMHS) Annual Conference , 21/08/2019 to 21/08/2019, USM (National)
  • Haplo-HSCT : Malaysian experience, 23rd Malaysian Society Of Paediatric Haematology & Oncology (MASPHO) Annual Scientific Meeting, 04/08/2018 to 05/08/2018, Malaysian Society Of Paediatric Haematology & Oncology (MASPHO)  (National)
  • INVITED SEMINAR
  • NHAM : Chemo-induced cardiovascular disease, National Heart Association Of Malaysia Annual Scientific Meeting 2017, 07/04/2017 to 09/04/2017, National Heart Association Malaysia (NHAM)  (National)
  • INVITED SPEAKER
  • Haploidentical Hematopoeitic Stem Cell Transplantation : UMMC Experience, 8th Malaysian Tissue Engineering & Regenerative Medicine Scientific Meeting, 30/03/2022 to 31/03/2022, Malaysian Tissue Engineering & Regenerative Medicine Society (National)
  • HLA-Haploidentical transplants : donor choice, 48th Annual Meeting of European Bone Marrow Transplantation Consortium, 19/03/2022 to 23/03/2022, European Bone Marrow Transplantation Consortium (International)
  • Premature Aging in Childhood Cancer Survivors, 11th Asia-Pacific Paed Endocrine Society Scientific Congress, 26/11/2021 to 28/11/2021, Asia-Pacific Paed Endocrine Society  (International)
  • Juvenile Myelomonocytic Leukemia, 25th ASM of Malaysian Soc of Paed Haematology-Oncology (MASPHO), 26/06/2021 to 27/06/2021, Malaysian Soc of Paed Haematology-Oncology (MASPHO) (National)
  • Childhood Cancer Services in Malaysia, Annual Scientific Meeting of Indonesian Paediatric Society, 11/04/2021 to 11/04/2021, Indonesian Paediatric Society (International)
  • Use of Antifungal Agents in Children with Cancer, XIIIth SIOP-Asia Congress, 21/03/2021 to 22/03/2021, International Soc of Paediatric Oncology (SIOP) (International)
  • Clinical implications of precision medicine, UKM post-grad research week, 02/09/2020 to 02/09/2020, UKM (National)
  • Translating research into personalized therapy for cALL, 1st MACR SCIENTIFIC CONFERENCE 2019, 04/12/2019 to 04/12/2019, Malaysian Association for Cancer Research (MACR) (National)
  • Bedside to Bench and Back, Faculty of Medicine Research Carnival 2019, 25/11/2019 to 25/11/2019, Faculty of Medicine, University of Malaya (University)
  • Immune hemolytic anemia in children, Red Cell Workshop, Ampang Hospital, 16/08/2019 to 16/08/2019, Ministry of Health (Government Sector/public Institution)
  • Primary immunodeficiencies, Continuous Medical Education, 23/05/2019 to 23/05/2019, Paediatric Department, University Malaya (University)
  • Building research success from failures, Anugerah Akademik Negara (AAN) Sharing session, Putrajaya, 24/04/2019 to 24/04/2019, Anugerah Akademik Negara (AAN) (National)
  • Long-term health challenges in childhood cancer survivors, 52nd Malaysia-Singapore Congress of Medicine, 29/07/2018 to 29/07/2018, Academy of Medicine of Malaysia (AMM) (International)
  • HSCT for SCID : UMMC Experience, 18th Malaysian Congress and Exhibition on Allergy and Immunology , 08/04/2018 to 08/04/2018, Malaysian Society of Allergy & Immunology (MSAI) (National)
  • Principles of administration of high-dose methotrexate, The 12th St Jude-VIVA Forum , 09/03/2018 to 09/03/2018, St Jude-VIVA Forum  (International)
  • Lab tests in management of childhood cancer, Year 1 Intensive Course, UM, 07/02/2018 to 07/02/2018, Univerity of Malaya (University)
  • Overview of childhood leukemia, Year 1 Intensive Course, UM, 07/02/2018 to 07/02/2018, University of Malaya (University)
  • Experience in haplo-BMT for infants with SCID, Experience in haplo-BMT for infants with SCID, 03/12/2017 to 03/12/2017, MALAYSIAN PATIENT ORGANISATION FOR PRIMARY IMMUNODEFICIENCIES, (MyPOPI) (National)
  • Non-precise yet personalized: Haplo-BMT, 11th National Committee for Clinical Research (NCCR), 27/09/2017 to 27/09/2017, American Congress of Rehabilitation Medicine (ACRM) (International)
  • Blame The Parents : Early-life origins of adult diseases, Blame The Parents , 09/08/2017 to 09/08/2017, Publika  (National)
  • CCS: Clinical-Cellular Correlations, 22nd Malaysian Society of Paediatric Haematology and Oncology: Paediatric Brain umours, 06/08/2017 to 06/08/2017, Malaysian Society of Paediatric Haematology and Oncology (MASPHO) (National)
  • Future of HSCT, FOM Research Week , 10/07/2017 to 10/07/2017, Faculty of Medicine, University of Malaya (University)
  • NHL: Outcomes (Malaysian perspectives) + HaploHSCT, 11TH ST JUDE-VIVA FORUM IN PAEDIATRIC ONCOLOGY, 03/03/2017 to 03/03/2017, St Jude and VIVA Foundation for Children with Cancer  (International)
  • Basics of Bone Marrow Transplant, Winter Course ; Gadjah Mada, Indonesia, 16/01/2017 to 16/01/2017, Gadjah Mada University, Indonesia (International)
  • Intensive Course Master of Pediatric Year 1 , Series of lectures; Department of Pediatric, 11/01/2017 to 11/01/2017, Department of Pediatric, University of Malaya (University)
  • Haplo-HSCT, Paediatric Department Continuous Medical Education: Haplo-HSCT, 02/12/2016 to 02/12/2016, Paediatric Department, UMMC (University)
  • Childhood Leukemia: personalized & targeted therapy, UMMP Paediatric Lecture, 18/11/2016 to 18/11/2016, UMMP (University)
  • Challenges in developing a common ALL protocol, Art of Haematology, 12/11/2016 to 12/11/2016, Sanofi, KL (Industry/company)
  • Haemophilia, UMMP_ Haemophilia, 24/09/2016 to 24/09/2016, UMMP (National)
  • Paed Oncology Update : Leukemia and Onco Emergencies, Paed Oncology Update, 17/09/2016 to 17/09/2016, Ministry of Health (National)
  • Evolution of Paediatric Oncology Therapy, Pharmacy Department Seminar, 20/08/2016 to 20/08/2016, Pharmacy Department, UMMC (University)
  • Haplo-HSCT_Chimerism analysis, ITL-POL joint meeting, 10/08/2016 to 10/08/2016, Pediatric Department (University)
  • TEDtalk : Dream , TEDtalk : Dream , 11/06/2016 to 11/06/2016, Sri KDU Schools (Others)
  • Should the MCC be modified for Asians, THE 2016 INTERNATIONAL LFS CONFERENCE & THE 3RD ANNUAL LIFE CONSORTIUM AND LFS ASSOCIATION CONFERENCE, 01/06/2016 to 03/06/2016, LI-FRAUMENI SYNDROME ASSOCIATION (International)
  • Haplo-HSCT, CME, 25/05/2016 to 25/05/2016, Universiti of Malaya (University)
  • Childhood Leukemia Update, Childhood Leukemia Update, 21/05/2016 to 21/05/2016, Ministry of Health (Government Sector/public Institution)
  • Use of social media in research, UiTM conference, 16/05/2016 to 17/05/2016, UiTM (National)
  • Acute Leukemia : Paediatric Perspectives, 13th Malaysian Society of Haematology Annual Scientific Meeting, 14/04/2016 to 16/04/2016, Malaysian Society of Haematology  (National)
  • Networks and Collaboration in Asia, 10TH ST JUDE-VIVA FORUM IN PAEDIATRIC ONCOLOGY, SINGAPORE, 05/03/2016 to 06/03/2016, ST JUDE-VIVA (International)
  • Research opportunities in Malaysia, Malaysian Medical Student Summit 2015, 01/08/2015 to 02/08/2015, Malaysian Medics International - MMI (National)
  • Translating genetic info into a personalized reaction of cALL, Human Genome Meeting 2015, Transforming Human Genomics for a Sustainable Tomorrow, , 14/03/2015 to 17/03/2015, Human Genome Organisation (International)
  • Hereditary cancers : Malaysian perspectives, SIOP 2014, 46th Congress of the International Society of Paediatric Oncology, 22-25 October 2014, Toronto, Canada, 22/10/2014 to 25/10/2014, International Society of Paediatric Oncology (International)
  • Personalised medicine in childhood leukemia, MASPHO 19th Annual Scientific Meeting 2014, 20/09/2014 to 21/09/2014, Malaysian Society of Paediatric Haematology and Oncology (National)
  • Paediatric oncology in Malaysia , 8th SIOP Asia, Seoul, 17/04/2014 to 19/04/2014, International Society of Pediatric Oncology (International)
  • Historical perspectives in paediatric oncology, World Cancer Day Conference , 2014, 22/02/2014 to 22/02/2014, National Cancer Society Malaysia: NCSM (International)
  • Li-Fraumeni Syndrome : The Malaysian Experience, Annual Scientific Meeting of Malaysian Oncological Society 2013, 29/11/2013 to 30/11/2013, Malaysian Oncological Society  (National)
  • LFS and inherited cancers : Malaysian perspective, Annual Scientific Congress of Malaysian Oncological Society 2013, 29/11/2013 to 01/12/2020, Malaysian Oncological Society (National)
  • Personalized therapy in childhood ALL, 1st National Conference for Cancer Research, 08/11/2013 to 10/11/2013 (National)
  • Tumour Lysis Syndrome, 24th Annual Scientific Meeting of Malaysian Society of Paediatric Haematology-Oncology, 21/09/2013 to 22/09/2013, Malaysian Society of Paediatric Haematology-Oncology (National)
  • Genetics, Ethics, Medicine, Genetics, Ethics, Medicine, 15/07/2013 to 16/07/2013, University of Malaya (University)
  • Inflammation and Cancer, 9th Congress of the Asian Society of Paediatric Research, 11/05/2013 to 12/05/2013, Asian Society of Paediatric Research (International)
  • Inflammation and Cancer, ASPR-PSM2013, 09/05/2013 to 12/05/2013, Perinatal Society of Malaysia (National)
  • Estimating the prevalence in Li-Fraumeni syndrome, "Heterogeneity and Anticipation in Li-Fraumeni Syndrome", 06/12/2012 to 07/12/2012, Institute for Advance Study, Princeton, New Jersey, USA (International)
  • Haematological Disorders in Children with Down Syndrome, Seminar on Paediatric Haematology, 10/05/2012 to 11/05/2012, Malaysian Society of Paediatric Haematology-Oncology (National)
  • Risk stratification of childhood leukemia, 7th Biennial Congress of International Society of Paediatric Oncology (SIOP, Asia), 22/04/2012 to 24/04/2012, International Society of Paediatric Oncology (SIOP, Asia) (International)
  • Personalized medicine : ALL, 5th Regional Conference On Molecular Medicine (RCMM) , 19/09/2011 to 20/09/2011, UKM, UMBI (National)
  • Engraftment studies post-HSCT, The Annual Scientific Meeting of College of Pathologists,2011, 27/06/2011 to 28/06/2011, Academy of Medicine of Malaysia (National)
  • Engraftment studies following haemopoetic stem cell transplantation, Transplant Pathology Updates,Malaysian College of Pathologists, 18/06/2011 to 19/06/2011, Malaysian College of Pathologists (National)
  • Bioinformatics, Bioinformatics, Acad, UM 2011, 01/06/2011 to 01/06/2011, Academy of Medicine of Malaysia (National)
  • Acute Myeloid Leukemia ; Malaysia-Singapore Study , St Jude Asia Forum 2008, 04/03/2008 to 07/04/2008, Viva Foundation, Singapore and St Jude Outreach (International)
  • Adjuvant chemotherapy in childhood brain tumours, National Conference of Neurosurgical Association of Malaysia, 07/06/2007 to 09/06/2007, Neurosurgical Association of Malaysia (National)
  • ORAL PRESENTER
  • Screening for oncogene fusion transcripts in childhood acute lymphoblastic leukemia using multiplex RT-PCR, 37th Congress of International Society of Paediatric Oncology (SIOP). Geneva, 20 24 Sep 2006, 20/09/2006 to 24/09/2006, International Society of Paediatric Oncology (SIOP) (International)
  • Safety and Efficacy of Carbapenems in Children, 26th Annual Congress of the Malaysian Paediatric Association, 02/09/2004 to 04/09/2004, Malaysian Paediatric Association (National)
  • POSTER PRESENTER
  • Cefepime monotherapy for treatment of febrile neutropenia, SIOP-Asia Congress, 04/04/2006 to 07/04/2006, International Society of Pediatric Oncology (SIOP) (International)
  • Mortality in Children with Acute Lymphoblastic Leukemia . , 36th Meeting of the International Society of Paediatric Oncology (SIOP) , 15/09/2004 to 19/09/2004, International Society of Paediatric Oncology (SIOP)  (International)
  • Haemophagocytosis in children, Haemophagocytosis in Malaysian Children . 26th Annual Congress of the Malaysian Paediatric Association. , 02/09/2004 to 04/09/2004, Malaysian Pediatric Association (National)
  • Primary intra-cranial germ-cell tumours ; 12-year experience from University of Malaya, 10th International Symposium of Paediatric Neuro-Oncology , 10/06/2002 to 12/06/2002, International Society of Paediatric Neuro-Oncology (International)
  • Long-term sequelae in childhood cancer survivors, 33rd Meeting of the International Society of Paediatric Oncology (SIOP) . Brisbane, 10-13 October 2001, 10/10/2001 to 13/10/2001, International Society of Paediatric oncology (SIOP) (International)
  • PRESENTER
  • UM-MOH Collaboration: Paediatric Oncology, UM-CRC Collaborative Meeting, 03/12/2016 to 03/12/2016, University of Malaya-Ministry of Health (National)